Another two urinary biomarkers, tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP-7), were also associated with VA-AKI and adverse events within nine months in a prospective multicenter study enrolling 333 critically ill adult patients [65]. This evidence concerns the gene TIMP2 and acute kidney injury.